Asia-Pacific Acute Myeloid Leukemia Treatment Companies

This report lists the top Asia-Pacific Acute Myeloid Leukemia Treatment companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Asia-Pacific Acute Myeloid Leukemia Treatment industry.

APAC Acute Myeloid Leukemia Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Asia-Pacific Acute Myeloid Leukemia Treatment Top Companies

  1. Abbvie

  2. Pfizer

  3. Teva Pharmaceutical Industries

  4. Sun Pharmaceuticals Industries

  5. Novartis

*Disclaimer: Top companies sorted in no particular order

Asia-Pacific Acute Myeloid Leukemia Treatment Market Major Players

Asia-Pacific Acute Myeloid Leukemia Treatment Market Concentration

Asia-Pacific Acute Myeloid Leukemia Treatment Market Concentration

Asia-Pacific Acute Myeloid Leukemia Treatment Company List

  • Astellas Pharma Inc.

  • AbbVie Inc.

  • Celgene Corporation

  • Daiichi Sankyo Company Limited

  • Novartis AG

  • Pfizer Inc.

  • Teva Pharmaceutical Industries Ltd

  • Viatris (Mylan NV)

  • Sun Pharmaceutical Industries Ltd

  • Fresenius SE & Co. KGaA


Specific to Asia-Pacific Acute Myeloid Leukemia Treatment Market
Need More Details on Market Players and Competiters?
Download PDF